MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
  • 2016 International Congress

    Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism

    S. Tashiro, K. Dashtipour, J.J. Chen, K. Frei, E. Rashidian (Loma Linda, CA, USA)

    Objective: The aim of this study was to review the published evidence for the efficacy, safety, and dosing practices of droxidopa treatment for symptomatic neurogenic…
  • 2016 International Congress

    Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?

    S.J. Kang, J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: To investigate the differences and similarities between SWEDD patients and PD patients using smell test. Background: The concept of SWEDD(scans without evidence of dopaminergic…
  • 2016 International Congress

    Olfactory testing in differential diagnosis of atypical essential tremor and tremor-dominant Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

    Objective: The aim of this study was to assess olfactory function using Sniffing Sticks Test in groups of patients with Parkinson's disease, and atypical extrapyramidal…
  • 2016 International Congress

    Emotional valence and arousal ratings from rewarding and fearful stimuli are not influenced by levodopa in Parkinson’s disease

    T. Serranova, T. Sieger, P. Dušek, E. Ruzicka, R. Jech (Prague, Czech Republic)

    Objective: To analyze the effects of levodopa on affective ratings of emotional valence and arousal to rewarding, fearful and neutral stimuli in PD patients and…
  • 2016 International Congress

    Longitudinal evolution of possible REM sleep behavior disorder in early Parkinson’s disease

    W. Oertel, T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, A. Iranzo, G. Mayer, L. Chahine, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Marburg, Germany)

    Objective: To examine longitudinal change in the REM behavior disorder (RBD) in the cohort of at baseline de novo Parkinson's disease (PD) subjects. Background: RBD…
  • 2016 International Congress

    Longitudinal evolution of excessive daytime sleepiness in early Parkinson’s disease

    T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

    Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) in the cohort of at baseline de novo Parkinson's disease (PD) subjects. Background: We have…
  • 2016 International Congress

    Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks

    C.A. Antoniades, P. Rebelo, C. Kennard, T. Aziz, A.L. Green, J.J. FitzGerald (Oxford, United Kingdom)

    Objective: To compare and contrast the effects of deep brain stimulation of (a) the subthalamic nucleus and (b) the globus pallidus interna on advanced Parkinson's…
  • 2016 International Congress

    Introducing the 2nd edition of the occupational therapy for people with Parkinson’s: Best practice guidance

    A. Aragon (Bath, United Kingdom)

    Objective: To disseminate best practice to Occupational Therapists (OTs) about Parkinson's. Background: 5 years after publication of the Occupational Therapy for people with Parkinson's: Best…
  • 2016 International Congress

    Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

    F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)

    Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…
  • « Previous Page
  • 1
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley